(0.23%) 5 111.59 points
(0.34%) 38 369 points
(0.27%) 15 971 points
(-1.29%) $82.77
(6.34%) $2.05
(-0.09%) $2 345.20
(-0.27%) $27.46
(3.95%) $958.55
(-0.22%) $0.933
(-0.33%) $10.99
(-0.54%) $0.796
(1.65%) $93.39
Live Chart Being Loaded With Signals
SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally...
Stats | |
---|---|
今日成交量 | 2.42M |
平均成交量 | 2.05M |
市值 | 14.16B |
EPS | HKD0 ( 2024-03-27 ) |
Last Dividend | HKD0.0700 ( 2023-09-14 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 10.84 |
ATR14 | HKD0.00700 (0.15%) |
音量 相关性
SSY Group Ltd 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
SSY Group Ltd 相关性 - 货币/商品
SSY Group Ltd 财务报表
Annual | 2023 |
营收: | HKD6.46B |
毛利润: | HKD3.49B (53.99 %) |
EPS: | HKD0.440 |
FY | 2023 |
营收: | HKD6.46B |
毛利润: | HKD3.49B (53.99 %) |
EPS: | HKD0.440 |
FY | 2022 |
营收: | HKD6.43B |
毛利润: | HKD3.44B (53.46 %) |
EPS: | HKD0.380 |
FY | 2021 |
营收: | HKD5.36B |
毛利润: | HKD3.17B (59.18 %) |
EPS: | HKD0.260 |
Financial Reports:
No articles found.
SSY Group Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.0600 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.160 (N/A) |
HKD0.0700 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.00500 | 2008-05-23 |
Last Dividend | HKD0.0700 | 2023-09-14 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 32 | -- |
Total Paid Out | HKD1.257 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.32 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.77 | |
Div. Directional Score | 10.00 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
9909.HK | Ex Dividend Knight | 2023-11-24 | Semi-Annually | 0 | 0.00% | |
2161.HK | Ex Dividend Junior | 2023-08-15 | Annually | 0 | 0.00% | |
1161.HK | Ex Dividend Knight | 2023-06-12 | Annually | 0 | 0.00% | |
0239.HK | Ex Dividend Knight | 2023-09-29 | Semi-Annually | 0 | 0.00% | |
3866.HK | Ex Dividend Junior | 2023-06-02 | Annually | 0 | 0.00% | |
1731.HK | Ex Dividend Junior | 2023-06-23 | Sporadic | 0 | 0.00% | |
0771.HK | Ex Dividend Junior | 2023-05-31 | Sporadic | 0 | 0.00% | |
2327.HK | Ex Dividend Junior | 2023-08-03 | Sporadic | 0 | 0.00% | |
1290.HK | Ex Dividend Junior | 2023-06-14 | Sporadic | 0 | 0.00% | |
0363.HK | Ex Dividend Knight | 2023-06-01 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.204 | 1.500 | 5.92 | 8.88 | [0 - 0.5] |
returnOnAssetsTTM | 0.110 | 1.200 | 6.33 | 7.59 | [0 - 0.3] |
returnOnEquityTTM | 0.199 | 1.500 | 8.91 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.338 | -1.000 | 6.62 | -6.62 | [0 - 1] |
currentRatioTTM | 2.03 | 0.800 | 4.84 | 3.87 | [1 - 3] |
quickRatioTTM | 1.587 | 0.800 | 5.37 | 4.30 | [0.8 - 2.5] |
cashRatioTTM | 0.659 | 1.500 | 7.45 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.282 | -1.500 | 5.31 | -7.96 | [0 - 0.6] |
interestCoverageTTM | 11.88 | 1.000 | 6.71 | 6.71 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.325 | 2.00 | 9.89 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0880 | 2.00 | 9.96 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.486 | -1.500 | 8.06 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.540 | 1.000 | 4.34 | 4.34 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.231 | 1.000 | 7.39 | 7.39 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.287 | 1.000 | 9.52 | 9.52 | [0.2 - 2] |
assetTurnoverTTM | 0.540 | 0.800 | 9.73 | 7.79 | [0.5 - 2] |
Total Score | 12.25 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.78 | 1.000 | 9.01 | 0 | [1 - 100] |
returnOnEquityTTM | 0.199 | 2.50 | 9.30 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0880 | 2.00 | 9.97 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.81 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.325 | 2.00 | 9.89 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.338 | 1.500 | 6.62 | -6.62 | [0 - 1] |
pegRatioTTM | 0.559 | 1.500 | 9.61 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.149 | 1.000 | 8.76 | 0 | [0.1 - 0.5] |
Total Score | 7.77 |
SSY Group Ltd
SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; and food, beverages, and catering business. It sells its products under Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was incorporated in 2004 and is headquartered in Wanchai, Hong Kong. SSY Group Limited is a subsidiary of China Pharmaceutical Co., Ltd.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。